Incidence of schizophrenia in Nottingham

Brewin, J.; Cantwell, Roch; Dalkin, T.; R, Fox; Medley, Ian; Glazebrook, Cris; Kwiecinski, Rosemary; Harrison, Glynn

doi:10.1192/bjp.171.2.140

Cited by 87 publications

(32 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, this was not the case, suggesting that 'nuclear' schizophrenia is more homogeneous and occurs at a very similar frequency in the different populations. In recent years, replications of the design of the WHO ten-country study using the same instruments and procedures have been carried out with very similar results by investigators in India (Rajkumar et al 1993), the Caribbean (Hickling & Rodgers-Johnson 1995;Mahy et al 1999), and the United Kingdom Brewin et al 1997). …”

Section: Incidencementioning

confidence: 84%

“…However, the data remain inconsistent or conflicting. Two studies Brewin et al 1997) provide prevalence and incidence data on urban areas that had been surveyed 5 years earlier (inner London) and 12 years earlier (Nottingham). The point prevalence in Hampstead increased from 4.7 per 1000 in 1986 to 5.1 per 1000 in 1991 but the 5-year interval between the two surveys may be too short for detecting any long-term trend.…”

Section: Declining Incidence Of Schizophreniamentioning

confidence: 99%

See 1 more Smart Citation

Epidemiology of schizophrenia: the global burden of disease and disability

Jablensky

2000

European Archives of Psychiatry and Clinical Neuroscience

375

220

View full text Add to dashboard Cite

Evidence from nearly a century of epidemiological research indicates that schizophrenia occurs in all populations with a prevalence in the range of 1.4 to 4.6 per 1000 and incidence rates in the range of 0.16-0.42 per 1000 population. Multi-centre studies conducted by the World Health Organization have highlighted important differences between 'Western' and 'Third World' populations as regards the course and outcome of the disorder, with a significantly better prognosis in the developing countries. The factors underlying the better outcome of schizophrenia in developing countries remain essentially unknown but are likely to involve interactions between genetic variation and specific aspects of the environment. These features place schizophrenia, along with diabetes, cancer and hypertension, into the group of genetically complex diseases which are characterised by polygenic transmission, locus heterogeneity and environmental contribution to causation. The emerging pattern of risk factors and antecedents of schizophrenia suggests multiple, mainly quantitative deviations from the average developmental trajectory, primarily in the areas of early neurodevelopment, cognitive ability and social behaviour. These deviations are compatible with the notion of non-specific background factors facilitating the operation of genetically determined causal pathways. Research likely to result in new insights should focus on the population distribution and behavioural effects of potential risk factors and markers suggested by biological and genetic research.

show abstract

Section: Incidencementioning

confidence: 84%

Section: Declining Incidence Of Schizophreniamentioning

confidence: 99%

Epidemiology of schizophrenia: the global burden of disease and disability

Jablensky

2000

European Archives of Psychiatry and Clinical Neuroscience

375

220

View full text Add to dashboard Cite

show abstract

“…A Nottingham, UK, study examining the incidence of first-episode psychotic disorders in two cohorts, 1978-80 and 1992-4, found that the age-standardised incidence rates for schizophrenia and related disorders was 0.14 per 1000 per year. 33 They found that the rate for all psychoses rose slightly (but not statistically significantly so) but the rate for schizophrenia only had a significant decline. This suggested that an apparent reduction in schizophrenia incidence over time was likely to be due to the range of other psychosis diagnoses being made in the later cohort.…”

Section: Incidence Of Psychosismentioning

confidence: 99%

“…This suggested that an apparent reduction in schizophrenia incidence over time was likely to be due to the range of other psychosis diagnoses being made in the later cohort. 33 A study of the annual incidence of schizophrenia and non-affective psychosis in London found a rate of 0.22 per 1000 [95% confidence interval (CI) 0.15 to 0.29 per 1000]. 34 In a recent Irish study, the annual incidence of all psychoses in people aged over 15 years was estimated to be 0.32 per 1000.…”

Section: Incidence Of Psychosismentioning

confidence: 99%

See 1 more Smart Citation

Structural neuroimaging in psychosis: a systematic review and economic evaluation

Albon¹,

Tsourapas²,

Frew³

et al. 2008

Health Technol Assess

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) Programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, the public and consumer groups and professional bodies such as royal colleges and NHS trusts. These sugges...

show abstract